Cerci, K. and Patir, P. (2023) “Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation”, Global Journal of Medical and Clinical Case Reports, 10(1), pp. 001–002. doi: 10.17352/2455-5282.000167.